ABSTRACT
Long-chain fatty acids (LCFAs) are a major caloric component of our diet and are key metabolites for energy generation and storage. Physiological uptake of LCFAs across cell membranes is a saturable and competable process occurring at low concentrations, indicative of protein-mediated transport. Fatty acid transport proteins are a family of transmembrane proteins that enhance LCFA uptake and are produced in all fatty acid-utilizing tissues. Here, we review our current understanding of the function, expression patterns and regulation and subcellular localization of this interesting family of proteins.
Subject(s)
Carrier Proteins , Membrane Proteins , Membrane Transport Proteins , Animals , Biological Transport , Carrier Proteins/analysis , Carrier Proteins/genetics , Carrier Proteins/physiology , Fatty Acid Transport Proteins , Fatty Acids/metabolism , Gene Expression Regulation , Humans , Membrane Proteins/analysis , Membrane Proteins/genetics , Membrane Proteins/physiology , Subcellular Fractions/chemistryABSTRACT
Long-form leptin receptor (OB-R(L)) is a signal-transducing member of the cytokine receptor superfamily that is essential for mediating the effects of leptin on mammalian body weight homeostasis. At present, the range of transcriptional targets responsive to OB-R(L) activation, and consequently, the likely mediators of leptin action, remain undefined. In this report, we have used cDNA subtractive hybridization to identify transcripts induced by leptin in immortalized hypothalamic neurons expressing OB-R(L). Differential expression of the identified transcripts in these cells was confirmed by both array technology and Northern blotting. In situ hybridization studies indicate that these transcripts are expressed in the mouse central nervous system, including nuclei of the hypothalamus that coexpress OB-R(L). Comparative in situ analysis of slices of hypothalami generated from control and leptin-injected ob/ob mice demonstrates that a subset of the identified transcripts is induced in vivo after leptin injection. The potential role of the proteins encoded by these transcripts in mediating the effects of leptin on body weight and energy homeostasis are discussed.
Subject(s)
Brain/metabolism , Carrier Proteins/genetics , Hypothalamus/metabolism , Leptin/pharmacology , Neurons/metabolism , Receptors, Cell Surface , Transcription, Genetic/drug effects , Adenoviridae , Animals , Cell Line , Gene Expression Regulation/drug effects , Gene Library , Genetic Vectors , In Vitro Techniques , Male , Mice , Mice, Obese , Organ Specificity , Receptors, Leptin , Recombinant Proteins/biosynthesis , TransfectionABSTRACT
When prevention fails, medicinal treatment of obesity may become a necessity. Any strategic medicinal development must recognize that obesity is a chronic, stigmatized and costly disease that is increasing in prevalence. Because obesity can rarely be cured, treatment strategies are effective only as long as they are used, and combined therapy may be more effective than monotherapy. For a drug to have significant impact on body weight it must ultimately reduce energy intake, increase energy expenditure, or both. Currently approved drugs for long-term treatment of obesity include sibutramine, which inhibits food intake, and orlistat, which blocks fat digestion.
Subject(s)
Anti-Obesity Agents/therapeutic use , Obesity/drug therapy , Adipose Tissue/drug effects , Dietary Fats/metabolism , Eating/drug effects , Energy Metabolism/drug effects , Humans , Intestinal Absorption/drug effects , Neuropeptides/drug effects , Neuropeptides/physiologyABSTRACT
We recently reported that intraperitoneal administration of leptin-related synthetic peptide 116-130 [LEP-(116-130)] resulted in reduced food intake and significant weight loss in homozygous female C57BL/6J ob/ob mice. In this study, we used two in vitro bioassays to show that the interaction of LEP-(116-130) with the long form of the leptin receptor (OB-Rb), the receptor isoform that is predominantly expressed in the hypothalamus, is not required for the observed in vivo effects of the peptide on energy balance. LEP-(116-130) was unable to compete the binding of alkaline phosphatase-leptin fusion protein to OB-R. Moreover, LEP-(116-130) was unable to activate signal transduction by OB-Rb in vitro. In homozygous female C57BLKS/J-m db/db mice that do not express OB-Rb, intraperitoneal administration of LEP-(116-130) reduced body weight gain and blood glucose levels but not food intake, which further supports a mechanism of action that does not require peptide interaction with OB-Rb.
Subject(s)
Blood Glucose/metabolism , Carrier Proteins/physiology , Feeding Behavior/drug effects , Leptin/pharmacology , Peptide Fragments/pharmacology , Receptors, Cell Surface , Weight Gain/drug effects , Animals , Blood Glucose/drug effects , Body Temperature Regulation/drug effects , COS Cells , Carrier Proteins/drug effects , Carrier Proteins/genetics , Cell Line , Feeding Behavior/physiology , Female , Homozygote , Hypothalamus/physiology , Ligands , Mice , Mice, Inbred C57BL , Mice, Obese , Receptors, Leptin , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism , Transfection , Weight Gain/physiologyABSTRACT
While intestinal transport systems for metabolites such as carbohydrates have been well characterized, the molecular mechanisms of fatty acid (FA) transport across the apical plasmalemma of enterocytes have remained largely unclear. Here, we show that FATP4, a member of a large family of FA transport proteins (FATPs), is expressed at high levels on the apical side of mature enterocytes in the small intestine. Further, overexpression of FATP4 in 293 cells facilitates uptake of long chain FAs with the same specificity as enterocytes, while reduction of FATP4 expression in primary enterocytes by antisense oligonucleotides inhibits FA uptake by 50%. This suggests that FATP4 is the principal fatty acid transporter in enterocytes and may constitute a novel target for antiobesity therapy.
Subject(s)
Carrier Proteins/isolation & purification , Enterocytes/metabolism , Fatty Acids/metabolism , Intestine, Small/metabolism , Membrane Proteins/isolation & purification , Membrane Transport Proteins , Binding, Competitive , Biological Transport , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Polarity , Enterocytes/ultrastructure , Fatty Acid Transport Proteins , Humans , Intestine, Small/ultrastructure , Membrane Proteins/genetics , Membrane Proteins/metabolism , Methionine/metabolism , Microvilli/chemistry , Microvilli/ultrastructure , Oleic Acid/metabolism , Oligonucleotides, Antisense , Palmitates/metabolism , Substrate SpecificityABSTRACT
Uncoupling protein 1 (UCP1) dissipates energy and generates heat by catalyzing back-flux of protons into the mitochondrial matrix, probably by a fatty acid cycling mechanism. If the newly discovered UCP2 and UCP3 function similarly, they will enhance peripheral energy expenditure and are potential molecular targets for the treatment of obesity. We expressed UCP2 and UCP3 in Escherichia coli and reconstituted the detergent-extracted proteins into liposomes. Ion flux studies show that purified UCP2 and UCP3 behave identically to UCP1. They catalyze electrophoretic flux of protons and alkylsulfonates, and proton flux exhibits an obligatory requirement for fatty acids. Proton flux is inhibited by purine nucleotides but with much lower affinity than observed with UCP1. These findings are consistent with the hypothesis that UCP2 and UCP3 behave as uncoupling proteins in the cell.
Subject(s)
Carrier Proteins/metabolism , Membrane Transport Proteins , Mitochondria/metabolism , Mitochondrial Proteins , Proteins/metabolism , Carrier Proteins/antagonists & inhibitors , Fatty Acids/pharmacology , Humans , Ion Channels , Kinetics , Lauric Acids/pharmacology , Proteins/antagonists & inhibitors , Purine Nucleotides/pharmacology , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/genetics , Spectrometry, Fluorescence , Uncoupling Protein 2 , Uncoupling Protein 3ABSTRACT
A mutation in the tub gene leads to maturity-onset obesity, insulin resistance, and progressive retinal and cochlear degeneration in mice. tub is a member of a growing family of genes that encode proteins of unknown function that are remarkably conserved across species. The absence of obvious transmembrane domain(s) or signal sequence peptide motif(s) suggests that Tub is an intracellular protein. Additional sequence analysis revealed the presence of putative tyrosine phosphorylation motifs and Src homology 2 (SH2)-binding sites. Here we demonstrate that in CHO-IR cells, transfected Tub is phosphorylated on tyrosine in response to insulin and insulin-like growth factor-1 and that in PC12 cells, insulin but not EGF induced tyrosine phosphorylation of endogenous Tub. In vitro, Tub is phosphorylated by purified insulin receptor kinase as well as by Abl and JAK 2 but not by epidermal growth factor receptor and Src kinases. Furthermore, upon tyrosine phosphorylation, Tub associated selectively with the SH2 domains of Abl, Lck, and the C-terminal SH2 domain of phospholipase Cgamma and insulin enhanced the association of Tub with endogenous phospholipase Cgamma in CHO-IR cells. These data suggest that Tub may function as an adaptor protein linking the insulin receptor, and possibly other protein-tyrosine kinases, to SH2-containing proteins.
Subject(s)
Insulin/metabolism , Phosphotyrosine/metabolism , Proteins/metabolism , Proto-Oncogene Proteins , src Homology Domains , Adaptor Proteins, Signal Transducing , Animals , CHO Cells , Cricetinae , Insulin-Like Growth Factor I/pharmacology , Janus Kinase 2 , Oncogene Proteins v-abl/metabolism , Phosphorylation , Protein Binding , Protein-Tyrosine Kinases/metabolism , Proteins/genetics , Receptor Protein-Tyrosine Kinases/metabolism , Receptor, Insulin/metabolism , Signal Transduction , TransfectionABSTRACT
Antibodies against Escherichia coli-expressed uncoupling protein-2 (UCP2) and uncoupling protein-3 (UCP3) were raised by operating the blotted proteins into the spleen of minipigs. The antisera reacted more intensively with the recombinant UCP2 and UCP3 than with uncoupling protein-1 (UCP1) isolated from brown adipose tissue. Moreover, anti-UCP2 and cross-reacting anti-UCP3 antibodies identified the presence of the UCP2/3 antigen in isolated mitochondria from rat heart, rat kidney, rat brain, rabbit epididymal white adipose tissue, hamster brown adipose tissue, and rabbit skeletal muscle. It has been concluded that UCP2 is expressed in these tissues (UCP3 in skeletal muscle); however their existence in mitochondria had not previously been demonstrated.
Subject(s)
Antibodies, Bacterial/metabolism , Membrane Transport Proteins , Mitochondria, Heart/metabolism , Mitochondria, Liver/metabolism , Mitochondrial Proteins , Proteins/metabolism , Animals , Antibody Specificity , Carrier Proteins/immunology , Carrier Proteins/metabolism , Cricetinae , Escherichia coli/genetics , Escherichia coli/immunology , Humans , Ion Channels , Proteins/immunology , Rabbits , Rats , Rats, Wistar , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Uncoupling Protein 2 , Uncoupling Protein 3ABSTRACT
The adipocyte secreted hormone leptin (OB) and its receptor (OB-R) are key regulators of mammalian body weight homeostasis. Two predominant isoforms of OB-R have been described: long form (OB-R(L)) characterized as a signal transducing receptor that is highly expressed in specific nuclei of the hypothalamus; and a short, signaling-defective form (OB-R(S)) of indeterminate function that is ubiquitously expressed throughout the body. Receptor chimera studies indicate that OB-R(L) signals via homo-oligomers. However, co-expression experiments have demonstrated that signaling by OB-R(L) is only marginally susceptible to dominant negative suppression by OB-R(S). In the present study we have used receptor epitope tagging to analyze the ligand-independent and -dependent association properties of OB-R(S) and OB-R(L). We present evidence for ligand-independent homo-oligomerization by both receptor isoforms. Ligand treatment of these complexes does not dramatically augment homo-oligomerization. In contrast, hetero-oligomerization between long and short OB-R cannot be detected in the absence of ligand but can be resolved in the presence of ligand. Deletion and substitution mutagenesis of the OB-R(L) intracellular domain indicates that ligand-independent homo-oligomerization by OB-R(L) is sensitive to reduction in JAK kinase recruitment capability, suggesting that JAK interaction and signaling competency may provide means for isoform specific OB-R sorting. These results are discussed with regard to possible mechanisms permitting efficient leptin-induced signaling by OB-R(L) in tissues that co-express OB-R(S).
Subject(s)
Carrier Proteins/metabolism , Protein Isoforms/metabolism , Proteins/metabolism , Receptors, Cell Surface , Signal Transduction , Amino Acid Sequence , Biopolymers , Cell Line , Epitopes/metabolism , Humans , Janus Kinase 3 , Leptin , Ligands , Protein-Tyrosine Kinases/metabolism , Receptors, LeptinABSTRACT
Leptin (OB), an adipocyte-secreted circulating hormone, and its receptor (OB-R) are key components of an endocrine loop that regulates mammalian body weight. In this report we have analyzed signal transduction activities of OB-R containing the fatty mutation [OB-R(fa)], a single amino acid substitution at position 269 (Gln --> Pro) in the OB-R extracellular domain that results in the obese phenotype of the fatty rat. We find that this mutant receptor exhibits both ligand-independent transcriptional activation via interleukin 6 and hematopoietin receptor response elements and ligand-independent activation of signal transducer and activator of transcription (STAT) proteins 1 and 3. However, OB-R(fa) is unable to constitutively activate STAT5B and is highly impaired for ligand induced activation of STAT5B compared with OB-R(wt). Introduction of the fatty mutation into a OB-R/G-CSF-R chimera generates a receptor with constitutive character that is similar but distinct from that of OB-R(fa). Constitutive mutant OB-R(fa) receptor signaling is repressed by coexpression of OB-R(wt). The implications of an extracellular domain amino acid substitution generating a cytokine receptor with a partially constitutive phenotype are discussed both in terms of the mechanism of OB-R triggering and the biology of the fatty rat.
Subject(s)
Carrier Proteins/metabolism , Glycine/metabolism , Mutation , Proline/metabolism , Receptors, Cell Surface , Receptors, Cytokine/metabolism , Signal Transduction , Animals , COS Cells , Carrier Proteins/genetics , Cell Line , Glycine/genetics , Proline/genetics , Receptors, Cytokine/genetics , Receptors, LeptinABSTRACT
Leptin, an adipocyte-secreted hormone, is one of the central regulators of body weight homeostasis. In humans and rodents, two major forms of leptin receptors (OB-R) are expressed. The short form (OB-RS), considered to lack signaling capability, is detected in many organs. In contrast, OB-R long form (OB-RL) predominates in the hypothalamus, but is also present at low levels in peripheral tissues. Transient transfection experiments have demonstrated that OB-RL transduces an intracellular signaling similar to interleukin (IL)-6 type-cytokine receptors. To define the specificity by which OB-R induces genes and cooperates with signal transduction pathways utilized by other hormones and cytokines, rat and human hepatoma cell lines were generated which stably express human OB-RL. Hepatoma cell lines selected for appreciable levels of OB-RL mRNA display enhanced leptin binding and responded to leptin with an IL-6 receptor-like signaling that includes the activation of STAT proteins, induction of acute-phase plasma proteins, and synergism with IL-1 and tumor necrosis factor-alpha. A leptin-mediated recruitment of phosphatidylinositol 3-kinase to insulin receptor substrate-2 was also detected. However, no significant tyrosine phosphorylation of insulin receptor substrate-2 and modulation of the immediate cell response to insulin were observed. The data suggest that OB-RL action in hepatic cells is equivalent to that of IL-6 receptor. However, leptin does not play a specific role in muting insulin action on hepatoma cells and therefore may not contribute to the diabetic symptoms associated with obesity.
Subject(s)
Antigens, CD/physiology , Carrier Proteins/physiology , Interleukin-6 , Liver/metabolism , Receptors, Cell Surface , Receptors, Interleukin/physiology , Acute-Phase Proteins/genetics , Animals , Carrier Proteins/genetics , DNA-Binding Proteins/physiology , Growth Inhibitors/pharmacology , Humans , Insulin , Leptin , Leukemia Inhibitory Factor , Lymphokines/pharmacology , Mice , Phosphatidylinositol 3-Kinases , Phosphotransferases (Alcohol Group Acceptor)/drug effects , Proteins/pharmacology , RNA, Messenger/analysis , Rats , Receptors, Interleukin-6 , Receptors, Leptin , STAT1 Transcription Factor , STAT3 Transcription Factor , Trans-Activators/physiology , Tumor Cells, CulturedABSTRACT
We have identified a novel cDNA encoding a protein highly homologous to the mammalian brown fat uncoupling protein (UCP). Unlike the known UCP, which is expressed specifically in brown adipose tissue, the UCP homolog (UCPH) mRNA is expressed in a variety of tissues, with predominant expression in human white adipose tissue and skeletal muscle. In the white adipose tissue of ob/ob and db/db mice, the UCPH transcript is induced approximately fivefold relative to lean littermate controls. Expression of murine UCPH in yeast results in growth inhibition under conditions that require aerobic respiration, but does not affect growth under anaerobic conditions. Furthermore, UCPH expression in yeast causes a decrease in the mitochondrial membrane potential, as judged by staining with the potential-sensitive dye DiOC6. These observations suggest that UCPH, like UCP, uncouples oxidative phosphorylation. The possibility that the UCPH protein is an important mediator of human thermogenesis is discussed.
Subject(s)
Body Temperature Regulation/drug effects , Carrier Proteins/chemistry , Carrier Proteins/genetics , Membrane Proteins/chemistry , Membrane Proteins/genetics , Amino Acid Sequence , Animals , Carrier Proteins/pharmacology , Cloning, Molecular , DNA, Complementary/analysis , Humans , Ion Channels , Membrane Proteins/pharmacology , Mice , Mice, Inbred C57BL , Mice, Obese , Mitochondrial Proteins , Molecular Sequence Data , Oxidative Phosphorylation/drug effects , RNA, Messenger/metabolism , Sequence Homology, Nucleic Acid , Uncoupling Agents/chemistry , Uncoupling Agents/pharmacology , Uncoupling Protein 1ABSTRACT
The leptin receptor (OB-R) mediates the weight regulatory effects of the adipocyte secreted hormone leptin (OB). Previously we have shown that the long form of OB-R, expressed predominantly in the hypothalamus, can mediate ligand-induced activation of signal transducer and activator of transcription factors 1, 3, and 5 and stimulate transcription via interleukin-6 and hematopoietin receptor responsive gene elements. Here we report that deletion and tyrosine substitution mutagenesis of OB-R identifies two distinct regions of the intracellular domain important for signaling. In addition, granulocyte-colony stimulatory factor receptor/OB-R and OB-R/granulocyte-colony stimulatory factor receptor chimeras are signaling competent and provide evidence that aggregation of two OB-R intracellular domains is sufficient for ligand-induced receptor activation. However, signaling by full-length OB-R appears to be relatively resistant to dominant negative repression by signaling-incompetent OB-R, suggesting that mechanisms exist to permit signaling by the long form of OB-R even in the presence [corrected] of excess naturally occurring short form of OB-R.
Subject(s)
Carrier Proteins/metabolism , Cytoplasm/metabolism , Receptors, Cell Surface , Receptors, Granulocyte Colony-Stimulating Factor/metabolism , Signal Transduction , Animals , COS Cells , Carrier Proteins/genetics , Cell Line , Mutagenesis , Receptors, Granulocyte Colony-Stimulating Factor/genetics , Receptors, Leptin , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolismABSTRACT
There has been intense recent interest in the molecules and pathways governing mammalian body weight regulation. Leptin (OB), an ancestral member of the cytokine family, is an adipocyte-secreted circulating hormone exhibiting weight regulatory properties. Recently, the leptin receptor (OB-R) was identified and shown to exhibit sequence homology and functional similarity to members of the class I cytokine receptor family. The mechanisms governing OB-R triggering and signal transduction have begun to be elucidated, providing new insight into the pathways controlling mammalian body weight homeostasis.
Subject(s)
Body Weight , Carrier Proteins/physiology , Proteins/physiology , Receptors, Cell Surface , Adipose Tissue/physiology , Animals , Cloning, Molecular , Hypothalamus/physiology , Leptin , Mice , Mice, Mutant Strains , Mice, Obese/physiology , Parabiosis , Receptors, Leptin , Signal TransductionABSTRACT
The rat fatty (fa) mutation produces profound obesity of early onset caused by hyperphagia, defective nonshivering thermogenesis, and preferential deposition of energy into adipose tissue. Genetic mapping studies indicate that fa and diabetes (db) are homologous loci in the rat and mouse genomes, respectively. It has been shown that db alleles carry mutations in the Lepr (leptin receptor) gene. This paper describes a point mutation in the fatty allele of Lepr. A nucleotide substitution at position 880 (A-->C) causes an amino acid substitution at position 269 (Gln-->Pro). The mutation generates a novel Msp I site that cosegregates with fa in 1,028 meioses examined in obese F2 progeny from two crosses (Bnx13M and WKYx13M) and is still segregating in three rat colonies. PCR-based mutagenesis was used to introduce the fa mutation into the mouse Lepr cDNA. Transient transfection studies indicate that the mutant Lepr cDNA has greatly reduced binding of leptin (Lep) at the cell surface. These data are strong evidence that the single nucleotide substitution in the fa allele of Lepr (Leprfa) is responsible for the obese phenotype.
Subject(s)
Carrier Proteins/genetics , Obesity/genetics , Receptors, Cell Surface , Receptors, Cytokine/metabolism , Amino Acid Sequence , Animals , Base Sequence , Leptin , Molecular Sequence Data , Point Mutation , Polymorphism, Restriction Fragment Length , Proteins/metabolism , Rats , Rats, Mutant Strains , Receptors, LeptinABSTRACT
The leptin receptor (OB-R) is a single membrane-spanning protein that mediates the weight regulatory effects of leptin (OB protein). The mutant allele (db) of the OB-R gene encodes a protein with a truncated cytoplasmic domain that is predicted to be functionally inactive. Several mRNA splice variants encoding OB-Rs with different length cytoplasmic domains have been detected in various tissues. Here we demonstrate that the full-length OB-R (predominantly expressed in the hypothalamus), but not a major naturally occurring truncated form or a mutant from found in db/db mice, can mediate activation of signal transducer and activator of transcription (STAT) proteins and stimulate transcription through interleukin 6 responsive gene elements. Reconstitution experiments suggest that, although OB-R mediates intracellular signals with a specificity similar to interleukin 6-type cytokine receptors, signaling appears to be independent of the gp130 signal transducing component of the interleukin 6-type cytokine receptors.
Subject(s)
Antigens, CD/physiology , Carrier Proteins/physiology , Milk Proteins , Receptors, Cell Surface , Receptors, Interleukin/physiology , Animals , Cell Line , Chlorocebus aethiops , DNA-Binding Proteins/physiology , Gene Expression Regulation , Macromolecular Substances , Mice , Obesity/physiopathology , Protein Binding , RNA, Messenger/genetics , Receptors, Interleukin-6 , Receptors, Leptin , STAT3 Transcription Factor , STAT5 Transcription Factor , Signal Transduction , Structure-Activity Relationship , Trans-Activators/physiology , Transcription, Genetic , TransfectionABSTRACT
Binding studies were conducted to identify the anatomical location of brain target sites for OB protein, the ob gene product. 125I-labeled recombinant mouse OB protein or alkaline phosphatase-OB fusion proteins were used for in vitro and in vivo binding studies. Coronal brain sections or fresh tissue from lean, obese ob/ob, and obese db/db mice as well as lean and obese Zucker rats were probed to identify potential central OB protein-binding sites. We report here that recombinant OB protein binds specifically to the choroid plexus. The binding of OB protein (either radiolabeled or the alkaline phosphatase-OB fusion protein) and its displacement by unlabeled OB protein was similar in lean, obese ob/ob, and obese db/db mice as well as lean and obese Zucker rats. These findings suggest that OB protein binds with high affinity to a specific receptor in the choroid plexus. After binding to the choroid plexus receptor, OB protein may then be transported across the blood-brain barrier into the cerebrospinal fluid. Alternatively, binding of OB protein to a specific receptor in the choroid plexus may activate afferent neural inputs to the neural network that regulates feeding behavior and energy balance or may result in the clearance or degradation of OB protein. The identification of the choroid plexus as a brain binding site for OB protein will provide the basis for the construction of expression libraries and facilitate the rapid cloning of the choroid plexus OB receptor.
Subject(s)
Brain/metabolism , Choroid Plexus/metabolism , Obesity/metabolism , Proteins/metabolism , Alkaline Phosphatase/metabolism , Animals , Autoradiography , Binding Sites , Iodine Radioisotopes , Leptin , Mice , Mice, Inbred C57BL , Mice, Obese , Organ Specificity , Rats , Rats, Zucker , Recombinant Fusion Proteins/metabolism , Recombinant Proteins/metabolism , TritiumABSTRACT
OB-R is a high affinity receptor for leptin, an important circulating signal for the regulation of body weight. We identified an alternatively spliced transcript that encodes a form of mouse OB-R with a long intracellular domain. db/db mice also produce this alternatively spliced transcript, but with a 106 nt insertion that prematurely terminates the intracellular domain. We further identified G --> T point mutation in the genomic OB-R sequence in db/db mice. This mutation generates a donor splice site that converts the 106 nt region to a novel exon retained in the OB-R transcript. We predict that the long intracellular domain form of OB-R is crucial for initiating intracellular signal transduction, and as a corollary, the inability to produce this form of OB-R leads to the severe obese phenotype found in db/db mice.
Subject(s)
Carrier Proteins/genetics , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/metabolism , Point Mutation , Proteins/metabolism , Receptors, Cell Surface , Receptors, Cytokine/genetics , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , DNA Primers/genetics , DNA, Complementary/genetics , Humans , Leptin , Mice , Mice, Inbred Strains , Mice, Obese , Molecular Sequence Data , Obesity/genetics , Obesity/metabolism , Phenotype , Polymerase Chain Reaction , Receptors, Leptin , Sequence Homology, Amino Acid , Signal TransductionABSTRACT
The ob gene product, leptin, is an important circulating signal for the regulation of body weight. To identify high affinity leptin-binding sites, we generated a series of leptin-alkaline phosphatase (AP) fusion proteins as well as [125I]leptin. After a binding survey of cell lines and tissues, we identified leptin-binding sites in the mouse choroid plexus. A cDNA expression library was prepared from mouse choroid plexus and screened with a leptin-AP fusion protein to identify a leptin receptor (OB-R). OB-R is a single membrane-spanning receptor most related to the gp130 signal-transducing component of the IL-6 receptor, the G-CSF receptor, and the LIF receptor. OB-R mRNA is expressed not only in choroid plexus, but also in several other tissues, including hypothalamus. Genetic mapping of the gene encoding OB-R shows that it is within the 5.1 cM interval of mouse chromosome 4 that contains the db locus.